Synthetic Biology for Biobased Polyisoprene

Introduction

Polyisoprene is the primary polymer in natural rubber, extensively used in tires, footwear, medical gloves, adhesives, and automotive components. Traditionally sourced from the rubber tree (Hevea brasiliensis), natural rubber is constrained by climatic dependence, disease susceptibility, and land-use conflicts. Meanwhile, petroleum-derived synthetic rubber contributes to fossil depletion and microplastic pollution.

Biobased polyisoprene offers a sustainable alternative by using engineered microbes to produce cis-1,4-polyisoprene, the same elastic polymer found in natural rubber. Through synthetic biology, researchers are reconstructing the rubber biosynthetic pathway in E. coli, yeast, and other microbial hosts, enabling scalable, low-carbon production of renewable rubber without reliance on plantations.

What Products Are Produced?

• Biobased cis-1,4-Polyisoprene – Drop-in alternative to natural and synthetic rubber
• Applications:
• Automotive tires and tubes
• Latex gloves and medical devices
• Industrial belts and seals
• Footwear and sports gear

Pathways and Production Methods

1. Isoprenoid Biosynthesis via MEP/MEV Pathways

• Glucose → pyruvate/glyceraldehyde-3P → IPP & DMAPP → farnesyl pyrophosphate (FPP) → cis-1,4-polyisoprene
• Built using either:
• MEP (methylerythritol phosphate) pathway (in E. coli)
• MEV (mevalonate) pathway (in yeast, Corynebacterium)

2. Rubber Synthase Expression

• Rubber biosynthetic genes (e.g., cis-prenyltransferase, rubber elongation factor) from Hevea brasiliensis or Parthenium argentatum (guayule) inserted into microbial hosts
• Microbes polymerize IPP/DMAPP into cis-1,4-polyisoprene chains

3. Whole-Cell Bioproduction in Fermenters

• Optimized strains grow in bioreactors using sugars, glycerol, or lignocellulosic hydrolysates
• Polymer is extracted post-fermentation via solvent-based methods

Catalysts and Key Tools Used

Microbial Platforms:

• E. coli, Saccharomyces cerevisiae, Corynebacterium glutamicum, Bacillus subtilis
• Pseudomonas putida (for terpene tolerance)

Key Enzymes:

• Isopentenyl diphosphate isomerase (IDI)
• Geranylgeranyl diphosphate synthase
• cis-prenyltransferases
• Rubber elongation factors (REFs)

Synthetic Biology Tools:

• Modular pathway assembly (BioBricks, MoClo)
• CRISPR-based metabolic rewiring
• Promoter/RBS tuning for flux balancing
• Adaptive laboratory evolution for yield and tolerance

Case Study: Bridgestone & Genencor/DuPont Industrial Biosciences

Highlights

• Engineered E. coli and yeast to produce biobased rubber precursors and polyisoprene
• Identified key bottlenecks in IPP accumulation and chain polymerization
• Demonstrated lab-scale rubber formation from microbial systems

Timeline

• 2010 – Research collaboration initiated to reduce rubber tree dependence
• 2014 – First successful microbial cis-polyisoprene production
• 2017 – Filed patents for biobased rubber via synthetic pathways
• 2022 – Scaled to fermentation volumes >1000 L in pilot studies

Global and Indian Startups Working in This Area

Global

• Genencor (DuPont) – Engineered microbes for polyisoprene biosynthesis
• Bridgestone – Biobased rubber through synthetic microbial systems
• BioAmber (Canada) – Terpenoid intermediates for rubber
• Isobionics – Biobased isoprenoids (platform for rubber monomers)

India

• IIT Delhi & CSIR-NCL Pune – Synthetic biology for isoprenoid pathways
• IISER Bhopal – Rubber elongation gene expression in microbes
• ICT Mumbai – Microbial fermentation of IPP/DMAPP analogs
• BIRAC & DBT programs – Funding biosynthetic rubber and bioplastic innovation

Market and Demand

The global natural and synthetic rubber market was valued at USD 45.5 billion in 2023, projected to reach USD 65.8 billion by 2030 (CAGR ~5.4%). Biobased polyisoprene is a niche but fast-growing segment, expected to grow at >12% CAGR, driven by:

Major Use Segments:

• Tire and automotive industry
• Medical latex products (gloves, catheters)
• Adhesives and elastic polymers
• Green footwear and apparel components

Key Growth Drivers

• Shortage and price volatility of natural rubber
• High CO₂ emissions from synthetic rubber
• Brand demand for sustainable tires and elastomers
• Synthetic biology enabling scalable biomanufacturing
• Cross-industry collaboration (auto + biotech)

Challenges to Address

• Low polyisoprene titers and chain lengths in microbes
• Difficulty in rubber recovery and purification
• Toxicity of intermediates (e.g., IPP, FPP) to host strains
• Need for cost-effective lignocellulosic sugar integration
• In India: Lack of bio-rubber scale-up infrastructure and policy incentives

Progress Indicators

• 2010–2013 – First microbial expression of rubber genes
• 2015 – Genencor patents filed on isoprenoid-to-rubber pathway
• 2018 – Pilot reactors for rubber bioproduction establised
• 2021 – Yield optimization using synthetic MVA pathway
• 2024 – Ongoing global interest in bio-rubber for EV tires and medical use

Microbial production of rubber precursors: TRL 6–7 (pre-commercial). Full polyisoprene biosynthesis in microbes: TRL 4–5 (lab to pilot). In India: TRL 3–5, with active R&D but limited fermentation pilots

Conclusion

Biobased polyisoprene represents a game-changing opportunity to replace petroleum and plantation-derived rubber with a renewable, scalable alternative. Through synthetic biology and microbial engineering, the path to green tires, gloves, and elastomers is rapidly opening.

India’s strong foundation in sugar fermentation and biotech research can position it as a key player in the bio-rubber revolution, especially as global brands seek sustainable raw materials in the face of climate and supply disruptions.

Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in